Immunogen | IMGN - Action



Action Changement Date
AbbVie USD 4.95B 13M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Amgen USD 6.22B 121M 2025-12
Astellas Pharma JPY 297.26B 9.92B 2025-03
AstraZeneca USD 6.59B 126M 2025-09
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Exelixis USD 27.4M 3.92M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Intrexon USD 287K 68K 2022-12
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 7.91M 840K 2025-12
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12